Genetic & Molecular Testing
- GENETIC & MOLECULAR TESTING · PRECISION DIAGNOSTICS
Decoding Cancer at the Molecular Level
Genetic & Molecular Testing has transformed the way cancer is diagnosed and treated by providing deeper insights into the biological and genetic characteristics of a tumour. Rather than relying solely on conventional diagnostic methods, these advanced tests identify specific genetic alterations, molecular markers, and protein expressions that influence how a cancer develops and responds to treatment. At Apulki Medical Centre, comprehensive in-house molecular diagnostics, including Next Generation Sequencing (NGS), Fluorescence In Situ Hybridisation (FISH), Immunohistochemistry (IHC), and genetic testing, play a vital role in enabling personalised and precision-driven cancer care.
- Why It Matters
Advanced Molecular Diagnostics for Precision Oncology
- Every cancer is biologically different, even when two patients have the same type of disease.
- Genetic and molecular testing helps clinicians understand these differences by analysing the unique genetic profile of a tumour.
- The information obtained from these tests supports more accurate diagnosis, helps determine the most effective treatment options, identifies patients who may benefit from targeted therapies or immunotherapy, and provides valuable insights into disease prognosis.
- This precision-based approach allows treatment decisions to be tailored to the individual characteristics of each patient's cancer.
- The Continuum of Care
All Your Diagnostics, Under One Roof
At Apulki Medical Centre, all molecular diagnostic services are available under one roof, ensuring greater convenience, faster turnaround times, and seamless coordination between the laboratory and the clinical team. Performing these specialised investigations in-house allows our oncologists, pathologists, and molecular scientists to work closely together, enabling timely diagnosis and quicker treatment planning without unnecessary delays. This integrated approach supports informed clinical decision-making and ensures that patients receive the right treatment at the right time.
- The Continuum of Care
All Your Diagnostics, Under One Roof
At Apulki Medical Centre, all molecular diagnostic services are available under one roof, ensuring greater convenience, faster turnaround times, and seamless coordination between the laboratory and the clinical team. Performing these specialised investigations in-house allows our oncologists, pathologists, and molecular scientists to work closely together, enabling timely diagnosis and quicker treatment planning without unnecessary delays. This integrated approach supports informed clinical decision-making and ensures that patients receive the right treatment at the right time.
- The Continuum of Care
The Technology Behind Precision Diagnosis
Our advanced diagnostic capabilities include Next Generation Sequencing (NGS), which analyses multiple genes simultaneously to identify mutations associated with different cancers and guide precision therapies. Fluorescence In Situ Hybridisation (FISH) detects specific genetic abnormalities that are important for diagnosing certain cancers and selecting appropriate treatments. Immunohistochemistry (IHC) evaluates protein expression within tumour cells, helping classify cancers and predict their response to therapy. In addition, genetic testing can identify inherited genetic changes that may increase an individual’s risk of developing certain cancers, enabling risk assessment, family counselling, and preventive care where appropriate.
Genetic and molecular testing is valuable across a wide range of cancers, including breast, lung, colorectal, ovarian, prostate, gastrointestinal, and blood cancers, among others. The results help clinicians determine whether targeted therapies, immunotherapies, or other precision treatments are likely to be beneficial, reducing unnecessary treatments and supporting a more personalised approach to cancer care. These tests also contribute to monitoring disease progression, evaluating treatment response, and identifying changes that may influence future treatment decisions.
At Apulki Medical Centre, Genetic & Molecular Testing forms an integral part of our precision oncology programme. By combining advanced laboratory technology, specialised expertise, and multidisciplinary collaboration, we provide accurate molecular insights that support timely diagnosis, personalised treatment planning, and evidence-based cancer care. Our commitment to in-house diagnostics ensures that patients benefit from comprehensive, coordinated, and precision-driven care throughout every stage of their treatment journey.